Identification of the growth hormone-releasing hormone analogue [Pro1, Val14]-hGHRH with an incomplete C-term amidation in a confiscated product.

In this work, a modified version of the 44 amino acid human growth hormone-releasing hormone (hGHRH(1-44)) containing an N-terminal proline extension, a valine residue in position 14, and a C-terminus amidation (sequence: PYADAIFTNSYRKVVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2 ) has been identified in a confiscated product by liquid chromatography-high resolution mass spectrometry (LC-HRMS). Investigation of the product suggests also an incomplete C-term amidation. Similarly to other hGHRH analogues, available in black markets, this peptide can potentially be used as performance-enhancing drug due to its growth hormone releasing activity and therefore it should be considered as a prohibited substance in sport. Additionally, the presence of partially amidated molecule reveals the poor pharmaceutical quality of the preparation, an aspect which represents a big concern for public health as well.

[1]  M. Thevis,et al.  Determination of prohibited, small peptides in urine for sports drug testing by means of nano-liquid chromatography/benchtop quadrupole orbitrap tandem-mass spectrometry. , 2012, Journal of chromatography. A.

[2]  K. Deventer,et al.  Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. , 2012, Drug testing and analysis.

[3]  Simone Esposito,et al.  Characterization and identification of a C-terminal amidated mechano growth factor (MGF) analogue in black market products. , 2012, Rapid communications in mass spectrometry : RCM.

[4]  Wilhelm Schänzer,et al.  Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls. , 2012, Methods.

[5]  M. Thevis,et al.  Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the Cologne Doping Control Laboratory 2009. , 2010, Drug testing and analysis.

[6]  P. Hemmersbach,et al.  Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. , 2010, Drug testing and analysis.

[7]  M. Thevis,et al.  Detection of His-tagged Long-R³-IGF-I in a black market product. , 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[8]  Jing-jing Liu,et al.  Production and enhanced biological activity of a novel GHRH analog, hGHRH with an N-terminal Pro-Pro extension. , 2004, Protein expression and purification.

[9]  M. Bach,et al.  Growth hormone secretagogues: mechanism of action and use in aging. , 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.